#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Karen Sims Email
Chief Medical Officer . Arbutus Biopharma Corporation
Warminster, PA
LocationPrimary Email
How to contact Karen Sims
Join and see Karen's contact info for free!Current Roles
Employees:
112Revenue:
$17.4MAbout
Arbutus Biopharma Corporation (Nasdaq: ABUS) is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases. The Company’s current focus areas include Hepatitis B virus (HBV), SARS-CoV-2, and other coronaviruses. In HBV, Arbutus is developing a RNAi therapeutic, oral capsid inhibitor, oral PD-L1 inhibitor, and oral RNA destabilizer that they intend to combine to improve the outcomes of patients with chronic HBV by suppressing viral replication, reducing surface antigen and reawakening the immune system. Arbutus’ lead compound, AB-729 is the only RNAi therapeutic with evidence of immune re-awakening and is currently being evaluated in multiple phase 2 clinical trials. Arbutus has an ongoing drug discovery and development program directed to identifying novel, orally active agents for treating coronavirus (including SARS-CoV-2). Arbutus is also exploring oncology applications for its internal PD-L1 portfolio.Arbutus Biopharma Corporation Address
701 Veterans CircleWarminster, PA
United States